Log In
Print
BCIQ
Print
Print this Print this
 

VentriGel

  Manage Alerts
Collapse Summary General Information
Company Ventrix Inc.
DescriptionInjectable hydrogel scaffold sourced from decellularized porcine cardiac connective tissues
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationCongestive heart failure (CHF)
Indication DetailsPrevent congestive heart failure (CHF) following myocardial infarction (MI)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today